Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? (Q51815043)

13 April 2018

title

Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? (English)

1 reference

13 April 2018

main subject

diagnosis

0 references

hepatocellular carcinoma

1 reference

6

1 reference

13 April 2018

author name string

Fabio Farinati

1

1 reference

13 April 2018

Dario Marino

2

1 reference

13 April 2018

Massimo De Giorgio

3

1 reference

13 April 2018

Anna Baldan

4

1 reference

13 April 2018

Maria Cantarini

5

1 reference

13 April 2018

Gianludovico Rapaccini

7

1 reference

13 April 2018

Paolo Del Poggio

8

1 reference

13 April 2018

Maria Anna Di Nolfo

9

1 reference

13 April 2018

Luisa Benvegnù

10

1 reference

13 April 2018

Marco Zoli

11

1 reference

13 April 2018

Franco Borzio

12

1 reference

13 April 2018

Mauro Bernardi

13

1 reference

13 April 2018

Franco Trevisani

14

1 reference

13 April 2018

language of work or name

English

0 references

publication date

1 March 2006

1 reference

13 April 2018

The American Journal of Gastroenterology

published in

1 reference

13 April 2018

volume

101

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

page(s)

524-532

1 reference

13 April 2018

Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Issues in screening and surveillance for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Screening for cancer in viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Alphafetoprotein: an obituary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Effect of c-myc, Ki-67, MMP-2 and VEGF expression on prognosis of hepatocellular carcinoma patients undergoing tumor resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

α‐Fetoprotein positively regulates cytochrome c‐mediated caspase activation and apoptosome complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

The promoting molecular mechanism of alpha-fetoprotein on the growth of human hepatoma Bel7402 cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

The intracellular mechanism of alpha-fetoprotein promoting the proliferation of NIH 3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2006.00443.X

10.1111/J.1572-0241.2006.00443.X

21 January 2018

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

16542289

1 reference

13 April 2018